|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.60 USD | -0.47% |
|
+1.05% | -28.14% |
| 06-02 | Daxor Says Received US Patent for Remote Blood Volume Monitor Technology | MT |
| 04-26 | 5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. | CI |
Evolution of the Average Target: Daxor Corporation
Evolution of the Target Price: Daxor Corporation
Changes in Analyst Recommendations: Daxor Corporation
82511d91724d6fe6e5a70.9PvipjG0Mu44oTtz6Fvjqknqvsel8A2Zz-c47JJk9aE.xaqn6kHEeZZI1WsDpDe7_iDT3ILCll6qg4FcmacwwMnZlLvwA-tcrAH0VA~2a23a9c6b7092203d242f6da14591761
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +7.65% | |||||
| Average | +7.65% | |||||
| Weighted average by Cap. | +7.65% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.60USD
Average target price
22.50USD
Spread / Average Target
+112.26%
High Price Target
23.00USD
Spread / Highest target
+116.98%
Low Price Target
22.00USD
Spread / Lowest Target
+107.55%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.60USD
Average target price
22.50USD
Spread / Average Target
+112.26%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Consensus Daxor Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
